UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000063125
Receipt number R000072259
Scientific Title The Effect of the Method of Explaining the Task in Advance on Postural Adjustment to Unpredictable Postural Perturbations
Date of disclosure of the study information 2026/11/20
Last modified on 2026/09/30 19:23:00

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The Effect of the Method of Explaining the Task in Advance on Postural Adjustment to Unpredictable Postural Perturbations

Acronym

The Effect of the Method of Explaining the Task in Advance on Postural Adjustment to Unpredictable Postural Perturbations

Scientific Title

The Effect of the Method of Explaining the Task in Advance on Postural Adjustment to Unpredictable Postural Perturbations

Scientific Title:Acronym

The Effect of the Method of Explaining the Task in Advance on Postural Adjustment to Unpredictable Postural Perturbations

Region

Japan


Condition

Condition

The Effect of the Method of Explaining the Task in Advance on Postural Adjustment to Unpredictable Postural Perturbations

Classification by specialty

Rehabilitation medicine Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim is to clarify the effects of the method of prior task explanation on the startle response and the subsequent rigid postural response to unpredictable postural perturbations, and to exploratorily examine the influence of individual characteristics on these responses.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Joint movement, and center-of-gravity displacement, derived from electromyography, joint motion, body center of gravity, and body sway.

Physical function(muscle strength, single-leg standing balance, joint range of motion, etc.), psychological and cognitive characteristics(dementia screening, personality tests, self-efficacy, etc.), physical activity levels(IPAQ, etc.), and fall history.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Cluster

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Other

Interventions/Control_1

Detailed description of the task (written, oral, video, etc.)

Interventions/Control_2

Detailed general description of the task (written, oral, video, etc.)

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

85 years-old >

Gender

Male and Female

Key inclusion criteria

Individuals aged 18 to 34, or 65 and older.
Individuals who are independent in their daily activities and able to walk indoors.
Individuals capable of understanding the explanation of the study details and tasks.
Individuals able to safely perform the standing postural perturbation task.
Individuals who can provide their own consent to participate in the study.

Key exclusion criteria

Individuals who have been advised by a physician to restrict physical activity.
Individuals experiencing severe pain or injury that affects standing, walking, joint movement, or the ability to exert force.
Individuals who experience severe dizziness, fainting, chest pain, or shortness of breath while standing or exercising.
Individuals whom the study staff deem unsuitable for participation on safety grounds.
For individuals with chronic illnesses, those currently taking medication, or those with a history of dizziness or fainting, eligibility will be determined on a case-by-case basis after assessing the stability of their condition and the potential impact on the study tasks.

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Satoshi
Middle name
Last name Kasahara

Organization

Hokkaido University

Division name

Department of Rehabilitation Science, Faculty of Health Sciences

Zip code

060-0812

Address

Kita 12 Nishi 5, Kita-Ku, Sapporo, Hokkaido, Japan

TEL

011-706-3390

Email

kasahara@hs.hokudai.ac.jp


Public contact

Name of contact person

1st name Satoshi
Middle name
Last name Kasahara

Organization

Hokkaido University

Division name

Department of Rehabilitation Science, Faculty of Health Sciences

Zip code

060-0812

Address

Kita 12 Nishi 5, Kita-Ku, Sapporo, Hokkaido, Japan

TEL

011-706-3390

Homepage URL


Email

kasahara@hs.hokudai.ac.jp


Sponsor or person

Institute

Hokkaido University

Institute

Department

Personal name



Funding Source

Organization

Hokkaido University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Hokkaido University, Department of Rehabilitation Science, Faculty of Health Sciences

Address

Kita 12 Nishi 5, Kita-Ku, Sapporo, Hokkaido, Japan

Tel

011-706-3316

Email

shomu@hs.hokudai.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 11 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 11 Month 20 Day

Date of IRB


Anticipated trial start date

2026 Year 11 Month 20 Day

Last follow-up date

2031 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 09 Month 30 Day

Last modified on

2026 Year 09 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072259